JPWO2020076790A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020076790A5 JPWO2020076790A5 JP2021519609A JP2021519609A JPWO2020076790A5 JP WO2020076790 A5 JPWO2020076790 A5 JP WO2020076790A5 JP 2021519609 A JP2021519609 A JP 2021519609A JP 2021519609 A JP2021519609 A JP 2021519609A JP WO2020076790 A5 JPWO2020076790 A5 JP WO2020076790A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743501P | 2018-10-09 | 2018-10-09 | |
| US62/743,501 | 2018-10-09 | ||
| PCT/US2019/055144 WO2020076790A1 (en) | 2018-10-09 | 2019-10-08 | Antibodies directed against staphylococcus aureus leukotoxins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512646A JP2022512646A (ja) | 2022-02-07 |
| JPWO2020076790A5 true JPWO2020076790A5 (enExample) | 2022-10-18 |
| JP7459075B2 JP7459075B2 (ja) | 2024-04-01 |
Family
ID=68393067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519609A Active JP7459075B2 (ja) | 2018-10-09 | 2019-10-08 | スタフィロコッカス・アウレウス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）ロイコトキシンに対して向けられた抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11059884B2 (enExample) |
| EP (1) | EP3864040A1 (enExample) |
| JP (1) | JP7459075B2 (enExample) |
| KR (1) | KR20210080411A (enExample) |
| CN (1) | CN113015745B (enExample) |
| AU (1) | AU2019359207A1 (enExample) |
| BR (1) | BR112021006704A2 (enExample) |
| CA (1) | CA3115765A1 (enExample) |
| MX (1) | MX2021004114A (enExample) |
| TW (1) | TWI895248B (enExample) |
| WO (1) | WO2020076790A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2917360T3 (da) * | 2012-11-06 | 2020-03-30 | Medimmune Llc | Antistoffer mod S. aureus-overflade-determinanter |
| CA3107463A1 (en) | 2018-07-24 | 2020-01-30 | Medimmune, Llc | Antibody directed against s. aureus clumping factor a (clfa) |
| JP7459075B2 (ja) | 2018-10-09 | 2024-04-01 | メディミューン，エルエルシー | スタフィロコッカス・アウレウス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）ロイコトキシンに対して向けられた抗体 |
| CN113164602A (zh) | 2018-10-09 | 2021-07-23 | 免疫医疗有限责任公司 | 抗金黄色葡萄球菌抗体的组合 |
| CN113811544A (zh) | 2019-03-13 | 2021-12-17 | 免疫医疗有限责任公司 | 减少定殖患者中的金黄色葡萄球菌感染 |
| CN113583119B (zh) * | 2021-07-07 | 2023-05-02 | 西北农林科技大学 | 抗金黄色葡萄球菌的纳米抗体Nb56、应用及试剂盒 |
| CN113493510A (zh) * | 2021-07-07 | 2021-10-12 | 上海交通大学 | 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| US6881557B2 (en) | 2001-07-12 | 2005-04-19 | Arrowsmith Technologies Llp | Super humanized antibodies |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| JP5675109B2 (ja) | 2007-02-20 | 2015-02-25 | アナプティスバイオ インコーポレイティッド | ライブラリーの生成方法及びその使用 |
| EP2391384A4 (en) | 2009-01-29 | 2012-12-26 | Medimmune Llc | HUMAN ANTI-IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-TIME AND USE THEREOF FOR TREATMENTS IN ONCOLOGY AND FOR AUTOIMMUNE AND IGNITION |
| BR112012029521A2 (pt) * | 2010-05-05 | 2018-03-06 | New York University | leucocidinas do staphylococcus aureus, composições terapêuticas, e aplicações das mesmas. |
| MX375113B (es) | 2011-02-08 | 2025-03-04 | Medimmune Llc | Anticuerpos que se unen específicamente a la toxina alfa de staphylococcus aureus y métodos de uso. |
| DK2917360T3 (da) | 2012-11-06 | 2020-03-30 | Medimmune Llc | Antistoffer mod S. aureus-overflade-determinanter |
| CN112316135A (zh) | 2012-11-06 | 2021-02-05 | 米迪缪尼有限公司 | 治疗金黄色葡萄球菌相关疾病的方法 |
| BR112016008275A2 (pt) * | 2013-10-17 | 2017-10-03 | Arsanis Biosciences Gmbh | Anticorpo com reatividade cruzada ao staphylococcus aureus, preparações farmacêuticas ou para diagnóstico compreendendo o anticorpo, anticorpo para uso médico e para diagnóstico, um ácido nucleico isolado que codifica o anticorpo, plasmideo ou cassete de expressao, e célula hospedeira compreendendo tal plasmideo ou cassete de expressao, método para produzir o anticorpo usando tal célula hospedeira, método para produzir variantes de anticorpos, um cristal formado por um monômero da hla ou lukd com dito anticorpo, um paratopo isolado do anticorpo, o epítopo isolado e uma molécula de ligação ligando especificamente ao dito epítopo, um método de triagem para identificar um ligante que se liga ao dito epítopo, um imunógeno compreendendo dito epítopo, e dito imunógeno usado para induzir uma resposta imune protetora |
| ES2869459T3 (es) | 2014-05-16 | 2021-10-25 | Medimmune Llc | Moléculas con unión a receptor de fc de neonato alterada que tiene propiedades terapéuticas y de diagnóstico potenciadas |
| TWI719938B (zh) | 2014-06-19 | 2021-03-01 | 美商麥迪紐有限責任公司 | 多重細菌感染之治療 |
| KR20170136637A (ko) | 2015-04-17 | 2017-12-11 | 알사니스 바이오사이언시스 게엠베하 | 항-스타필로코커스 아우레우스 항체 배합 제제 |
| US20190077851A1 (en) | 2015-10-30 | 2019-03-14 | Bruno Francois | Methods of using anti-alpha toxin antibody |
| CA3107463A1 (en) | 2018-07-24 | 2020-01-30 | Medimmune, Llc | Antibody directed against s. aureus clumping factor a (clfa) |
| JP7459075B2 (ja) | 2018-10-09 | 2024-04-01 | メディミューン，エルエルシー | スタフィロコッカス・アウレウス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）ロイコトキシンに対して向けられた抗体 |
| CN113164602A (zh) | 2018-10-09 | 2021-07-23 | 免疫医疗有限责任公司 | 抗金黄色葡萄球菌抗体的组合 |
-
2019
- 2019-10-08 JP JP2021519609A patent/JP7459075B2/ja active Active
- 2019-10-08 KR KR1020217013374A patent/KR20210080411A/ko active Pending
- 2019-10-08 CN CN201980074188.5A patent/CN113015745B/zh active Active
- 2019-10-08 MX MX2021004114A patent/MX2021004114A/es unknown
- 2019-10-08 US US16/596,445 patent/US11059884B2/en active Active
- 2019-10-08 EP EP19795711.1A patent/EP3864040A1/en active Pending
- 2019-10-08 BR BR112021006704-3A patent/BR112021006704A2/pt unknown
- 2019-10-08 AU AU2019359207A patent/AU2019359207A1/en active Pending
- 2019-10-08 WO PCT/US2019/055144 patent/WO2020076790A1/en not_active Ceased
- 2019-10-08 TW TW108136342A patent/TWI895248B/zh active
- 2019-10-08 CA CA3115765A patent/CA3115765A1/en active Pending
-
2021
- 2021-06-07 US US17/340,622 patent/US11578119B2/en active Active